Piramal Pharma Limited (NSE:PPLPHARMA)

India flag India · Delayed Price · Currency is INR
190.65
-6.38 (-3.24%)
Aug 1, 2025, 3:30 PM IST
-3.24%
Market Cap253.15B
Revenue (ttm)91.34B
Net Income (ttm)980.70M
Shares Out1.33B
EPS (ttm)0.73
PE Ratio260.14
Forward PE108.94
Dividend0.14 (0.07%)
Ex-Dividend DateJul 16, 2025
Volume5,046,588
Average Volume5,868,650
Open198.00
Previous Close197.03
Day's Range190.00 - 198.00
52-Week Range166.00 - 307.90
Beta0.06
RSI36.04
Earnings DateJul 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje... [Read more]

Sector Healthcare
Founded 2020
Employees 5,476
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.

Financial Statements

News

There is no news available yet.